EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Novel benzothiazole-indole acetamides as potential anticancer agents: synthesis, biological evaluation, and in silico studies

Nazanin Motamedi Shakib, Manica Negahdaripour iD, Mohammad Hosein Sayahi, Navid Dastyafteh, Zahra Dehghani, Mina Emami, Sajedeh Safapoor, Younes Ghasemi, Seyedeh Niloufar Ghafouri, Abbas Ghahramani, Mohammad Reza Mohajeri-Tehrani, Bagher Larijani und 2 weitere

RSC Advances · 2026 · 16 (33) · 30111-30123

DOI: 10.1039/d5ra08263c ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Nazanin Motamedi Shakib und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, College of Science, University of Tehran Tehran Iran. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Shiraz University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzothiazole-indole hybrids were synthesized and evaluated for antiproliferative effects. The most potent derivative was subjected to cell cycle and apoptosis investigations. Compound 9d is suggested as a promising anticancer agent.

Autor:innen und Institutionen

  • School of Chemistry, College of Science, University of Tehran Tehran Iran.
  • Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences Shiraz Iran ranjbar_sa@sums.ac.ir.
  • Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences Iran.
  • Department of Chemistry, Payame Noor University Tehran Iran.
  • Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences Tehran Iran.
  • Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.

ORCID-Profile: Manica Negahdaripour, Sara Ranjbar

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Motamedi Shakib, N., Negahdaripour, M., Sayahi, M. H., Dastyafteh, N., Dehghani, Z., Emami, M., Safapoor, S., Ghasemi, Y., Ghafouri, S. N., Ghahramani, A., Mohajeri-Tehrani, M. R., Larijani, B., Mahdavi, M., & Ranjbar, S. (2026). Novel benzothiazole-indole acetamides as potential anticancer agents: synthesis, biological evaluation, and in silico studies. RSC Advances, 16(33), 30111-30123. https://doi.org/10.1039/d5ra08263c

Vancouver

Motamedi Shakib N, Negahdaripour M, Sayahi MH, Dastyafteh N, Dehghani Z, Emami M, et al. Novel benzothiazole-indole acetamides as potential anticancer agents: synthesis, biological evaluation, and in silico studies. RSC Advances. 2026;16(33):30111-30123. doi:10.1039/d5ra08263c

BibTeX
@article{MotamediShakib2026,
  author = {Motamedi Shakib, Nazanin and Negahdaripour, Manica and Sayahi, Mohammad Hosein and Dastyafteh, Navid and Dehghani, Zahra and Emami, Mina and Safapoor, Sajedeh and Ghasemi, Younes and Ghafouri, Seyedeh Niloufar and Ghahramani, Abbas and Mohajeri-Tehrani, Mohammad Reza and Larijani, Bagher and Mahdavi, Mohammad and Ranjbar, Sara},
  title = {Novel benzothiazole-indole acetamides as potential anticancer agents: synthesis, biological evaluation, and in silico studies},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {33},
  pages = {30111--30123},
  doi = {10.1039/d5ra08263c}
}
Kostenlos starten →